PathologyJournal of Bone and Mineral ResearchPeer-reviewed
Effects of anti-RANKL, Zoledronate or combination therapy in a mouse model of Fibrous Dysplasia: a preclinical study
Biagio Palmisano, Chiara Tavanti, Giorgia Farinacci…·Mara Riminucci
This study evaluates the combination of zoledronate and anti-RANKL therapy in a mouse model of fibrous dysplasia, showing delayed disease rebound and improved bone density.
3 citationstop 1%